These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11794208)

  • 1. Management of tuberculosis.
    Fantry LE
    N Engl J Med; 2001 Nov; 345(20):1501-2. PubMed ID: 11794208
    [No Abstract]   [Full Text] [Related]  

  • 2. Efavirenz-rifampicin interaction: therapeutic drug monitoring to efavirenz dosage optimization in HIV/TBC patients.
    Cabrera SE; Cordero M; Iglesias A; Valverde MP; Domínguez-Gil A; García MJ
    AIDS; 2008 Nov; 22(18):2549-51. PubMed ID: 19005282
    [No Abstract]   [Full Text] [Related]  

  • 3. Saquinavir and rifampicin for tuberculosis and AIDS: new considerations.
    Torres TS; Rolla VC
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1302; author reply 1302-3. PubMed ID: 17131794
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis.
    Burman WJ; Gallicano K; Peloquin C
    Clin Infect Dis; 1999 Mar; 28(3):419-29; quiz 430. PubMed ID: 10194057
    [No Abstract]   [Full Text] [Related]  

  • 5. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
    Goldberg SV; Hanson D; Peloquin CA
    Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
    [No Abstract]   [Full Text] [Related]  

  • 7. Older antibiotic gains new respect as potent treatment for tuberculosis. Rifapentine is already approved for use with humans.
    Nuermberger E
    Home Healthc Nurse; 2008 Apr; 26(4):204-5. PubMed ID: 18408506
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of tuberculosis.
    Meissner PE; Coulter JB
    N Engl J Med; 2001 Nov; 345(20):1502. PubMed ID: 11794211
    [No Abstract]   [Full Text] [Related]  

  • 9. CDC lists options for managing rifampin, protease inhibitor therapy.
    Am J Health Syst Pharm; 1996 Dec; 53(24):2940; 2943. PubMed ID: 8974155
    [No Abstract]   [Full Text] [Related]  

  • 10. IDV concentrations plummet with rifampicin.
    Carter M
    IAPAC Mon; 2004 Feb; 10(2):53. PubMed ID: 15106521
    [No Abstract]   [Full Text] [Related]  

  • 11. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
    Tattevin P; Revest M; Dupont M; Arvieux C; Michelet C
    Clin Infect Dis; 2003 Jan; 36(1):127-8. PubMed ID: 12491218
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tuberculosis].
    Bonnaud F; Zigani A
    Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):151-4. PubMed ID: 18486058
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
    Kiuchi T; Tanaka K; Inomata Y; Uemoto S; Satomura K; Egawa H; Uyama S; Sano K; Okajima H; Yamaoka Y
    Transplant Proc; 1996 Dec; 28(6):3171-2. PubMed ID: 8962229
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampin in dermatology.
    Tsankov N; Angelova I
    Dis Mon; 2004 Jul; 50(7):369-80. PubMed ID: 15280868
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Centers for Disease Control and Prevention. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.
    JAMA; 1996 Nov; 276(19):1546. PubMed ID: 8918842
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of rifampin on cyclosporine disposition in kidney recipients with tuberculosis.
    Kim YH; Yoon YR; Kim YW; Shin JG; Cha IJ
    Transplant Proc; 1998 Nov; 30(7):3570-2. PubMed ID: 9838563
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 19. [An update on the antibiotic therapy of tuberculosis].
    Rossi G
    Recenti Prog Med; 1999 May; 90(5):241-3. PubMed ID: 10380549
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(42):921-5. PubMed ID: 8927017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.